Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07548372 · ClinicalTrials.gov registry record · NA
SPARK-CGM Implementation
A NA study, sponsored by Montefiore Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 20,000
- Enrollment target
NCT07548372 is a NA study that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 20,000 participants.
The verdict
NCT07548372, a NA study, is actively recruiting participants, sponsored by Montefiore Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 20,000 participants
- Enrollment target
Study Summary
Continuous glucose monitoring (CGM) is a technology that helps individuals with diabetes track their sugar levels in real-time, leading to more in-range blood sugars, fewer episodes of dangerously low blood sugar, and improved quality of life. Despite these benefits, CGM is not widely used in primary care settings, where most people receive their diabetes care. The investigators aim to make CGM more accessible and equitably prescribed in primary care practices. The study team will support primary care to increase CGM use with a program called SPARK-CGM (Supporting Primary Care Adoption, Resources, and Knowledge for CGM) across a large network of primary care clinics at Montefiore Medical Center. This program will provide primary care providers (PCPs) with education, tools, and support to incorporate CGM into their routine care for people with diabetes. Investigators plan to test SPARK-CGM to evaluate whether it increases CGM prescriptions who are eligible to receive this technology.
Interventions
- OTHER Standard of Care
- OTHER Enhanced CGM Interventions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2028-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07548372
The ClinicalTrials.gov registry entry for NCT07548372 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT07548372 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07548372 about?
NCT07548372 is a clinical study titled "SPARK-CGM Implementation". Continuous glucose monitoring (CGM) is a technology that helps individuals with diabetes track their sugar levels in real-time, leading to more in-range blood sugars, fewer episodes of dangerously low blood sugar, and improved quality of life. Despite these benefits, CGM is not widely used in primar...
What is the current status of trial NCT07548372?
This trial is currently recruiting. It is a NA study. The enrollment target is 20,000 participants. The study started on 2026-05-01. Estimated completion is 2028-05.
What interventions are being tested in trial NCT07548372?
The interventions under investigation include: Standard of Care (OTHER), Enhanced CGM Interventions (OTHER).
Who is sponsoring clinical trial NCT07548372?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.